X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (29191) 29191
Patent (3075) 3075
Newspaper Article (2141) 2141
Publication (1560) 1560
Newsletter (751) 751
Trade Publication Article (235) 235
Report (178) 178
Magazine Article (172) 172
Government Document (131) 131
Book Chapter (119) 119
Book Review (118) 118
Conference Proceeding (112) 112
Book / eBook (61) 61
Transcript (47) 47
Dissertation (38) 38
Web Resource (28) 28
Reference (12) 12
Paper (10) 10
Data Set (5) 5
Technical Report (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (10764) 10764
nitrogen (9742) 9742
male (9615) 9615
humans (8878) 8878
index medicus (8179) 8179
female (6725) 6725
blood urea nitrogen (4302) 4302
rats (4290) 4290
chemistry (4224) 4224
nitrogen - metabolism (3877) 3877
organic chemistry (3668) 3668
environmental sciences (3224) 3224
metallurgy (3085) 3085
acyclic, carbocyclic or heterocyclic compounds containingelements other than carbon, hydrogen, halogen, oxygen, nitrogen,sulfur, selenium or tellurium (3075) 3075
adult (3068) 3068
middle aged (2788) 2788
analysis (2721) 2721
human necessities (2701) 2701
research (2669) 2669
hygiene (2668) 2668
medical or veterinary science (2657) 2657
preparations for medical, dental, or toilet purposes (2637) 2637
air pollution (2217) 2217
nitrogen dioxide (2206) 2206
mice (2140) 2140
heterocyclic compounds (2067) 2067
nitrogen oxide (2046) 2046
dietary proteins - administration & dosage (1999) 1999
aged (1986) 1986
metabolism (1887) 1887
time factors (1794) 1794
creatinine - blood (1778) 1778
nitric oxide (1676) 1676
specific therapeutic activity of chemical compounds ormedicinal preparations (1660) 1660
diet (1611) 1611
proteins (1592) 1592
agriculture, dairy & animal science (1564) 1564
oxidative stress (1540) 1540
ecology (1517) 1517
carbon (1504) 1504
phosphorus (1451) 1451
pharmacology & pharmacy (1426) 1426
nutrition & dietetics (1413) 1413
studies (1384) 1384
medicine (1360) 1360
physiological aspects (1313) 1313
emissions (1305) 1305
growth (1282) 1282
rodents (1248) 1248
multidisciplinary sciences (1244) 1244
dose-response relationship, drug (1214) 1214
health aspects (1172) 1172
body weight (1166) 1166
organic compounds (1107) 1107
nutrients (1095) 1095
research article (1094) 1094
pollutants (1073) 1073
amino acids (1060) 1060
rats, wistar (1045) 1045
urea (1044) 1044
toxicology (1040) 1040
biochemistry & molecular biology (1025) 1025
nitrogen - analysis (1024) 1024
ammonia (1020) 1020
agriculture (1011) 1011
food science & technology (1010) 1010
science (1005) 1005
life sciences (988) 988
kidney - drug effects (987) 987
nitrogen - administration & dosage (977) 977
nitrogen oxides (958) 958
rats, sprague-dawley (957) 957
biomass (949) 949
kinetics (945) 945
physiology (942) 942
ecosystems (936) 936
enzymes (927) 927
drugs (923) 923
pollution (917) 917
environmental aspects (884) 884
environment (874) 874
inflammation (861) 861
adolescent (856) 856
fertilizers (849) 849
water quality (848) 848
organic nitrogen compounds (841) 841
toxicity (840) 840
disease models, animal (829) 829
bacteria (824) 824
nutrition (812) 812
nitrogen - urine (799) 799
energy intake (794) 794
meteorology & atmospheric sciences (794) 794
temperature (792) 792
cattle (790) 790
animal feed (785) 785
protein (779) 779
digestion (771) 771
dietary proteins - metabolism (768) 768
random allocation (766) 766
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (14) 14
Gerstein Science - Stacks (10) 10
Aerospace - Stacks (5) 5
Robarts - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Engineering & Comp. Sci. - Stacks (2) 2
Dentistry (Harry R Abbott) - Stacks (1) 1
Earth Sciences (Noranda) - Microtexts (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Robarts - Course Reserves (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (34615) 34615
French (1266) 1266
German (702) 702
Japanese (412) 412
Russian (312) 312
Chinese (207) 207
Spanish (141) 141
Polish (72) 72
Korean (70) 70
Italian (59) 59
Norwegian (56) 56
Danish (48) 48
Portuguese (44) 44
Czech (26) 26
Slovak (19) 19
Hungarian (15) 15
Swedish (13) 13
Dutch (11) 11
Finnish (9) 9
Croatian (8) 8
Ukrainian (8) 8
Bulgarian (7) 7
Serbian (7) 7
Hebrew (6) 6
Greek (5) 5
Slovenian (5) 5
Turkish (4) 4
Arabic (3) 3
Estonian (3) 3
Lithuanian (3) 3
Icelandic (2) 2
Romanian (2) 2
Indonesian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Blood, ISSN 0006-4971, 08/2015, Volume 126, Issue 6, pp. 721 - 732
Waldenstrom macroglobulinemia (WM) is a B-cell neoplasm manifested by the accumulation of clonal immunoglobulin (Ig)M-secreting lymphoplasmacytic cells. MYD88... 
CONSENSUS PANEL RECOMMENDATIONS | 2ND INTERNATIONAL WORKSHOP | L265P SOMATIC MUTATION | MULTIPLE-MYELOMA | RITUXIMAB THERAPY | IMMUNOGLOBULIN-M | MYD88 L265P | LYMPHOPROLIFERATIVE DISORDERS | LYMPHOPLASMACYTIC CELLS | INHIBITOR EVEROLIMUS | HEMATOLOGY | Cyclophosphamide - administration & dosage | Nitrogen Mustard Compounds - administration & dosage | Waldenstrom Macroglobulinemia - therapy | Humans | Middle Aged | Pyrazines - administration & dosage | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Transplantation, Autologous | Molecular Targeted Therapy | Waldenstrom Macroglobulinemia - pathology | Adult | Receptors, CXCR4 - genetics | B-Lymphocytes - pathology | Boronic Acids - administration & dosage | Everolimus | B-Lymphocytes - metabolism | Waldenstrom Macroglobulinemia - diagnosis | Immunoglobulin M - genetics | Gene Expression | Genetic Predisposition to Disease | Sirolimus - analogs & derivatives | Bortezomib | Pyrimidines - administration & dosage | Myeloid Differentiation Factor 88 - genetics | Antineoplastic Combined Chemotherapy Protocols | Hematopoietic Stem Cell Transplantation | Rituximab | Vidarabine - analogs & derivatives | Cladribine - administration & dosage | Plasmapheresis | Receptors, CXCR4 - metabolism | B-Lymphocytes - drug effects | Sirolimus - administration & dosage | Pyrazoles - administration & dosage | Bendamustine Hydrochloride | Aged | Oligopeptides - administration & dosage | Vidarabine - administration & dosage | Myeloid Differentiation Factor 88 - metabolism | Waldenstrom Macroglobulinemia - genetics
Journal Article
Radiation Research, ISSN 0033-7587, 06/2018, Volume 189, Issue 6, pp. 560 - 578
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 2014, Volume 106, Issue 8, pp. dju170 - dju170
This sixteenth biannual report of the Cochrane Haematological Malignancies Group highlights recently published randomized controlled trials (RCTs) in the field... 
SURVIVAL | OUTCOMES | ONCOLOGY | STEM-CELL TRANSPLANTATION | CHOP PLUS RITUXIMAB | Hematologic Neoplasms - therapy | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Lymphoma, Follicular - drug therapy | Primary Myelofibrosis | Nitrogen Mustard Compounds - administration & dosage | Humans | Pyrazines - administration & dosage | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Cyclophosphamide - adverse effects | Melphalan - adverse effects | Vincristine - administration & dosage | Boronic Acids - administration & dosage | Carmustine - adverse effects | Doxorubicin - administration & dosage | Lymphoma, Non-Hodgkin - drug therapy | Prednisone - administration & dosage | Bortezomib | Etoposide - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Drug Administration Schedule | Lymphoma, Mantle-Cell - drug therapy | Rituximab | Etoposide - administration & dosage | Nitrogen Mustard Compounds - adverse effects | Cytarabine - administration & dosage | Randomized Controlled Trials as Topic | Melphalan - administration & dosage | Pyrazoles - administration & dosage | Bendamustine Hydrochloride | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quality of Life | Vincristine - adverse effects | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Carmustine - administration & dosage
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9873, pp. 1203 - 1210
Summary Background Rituximab plus chemotherapy, most often CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), is the first-line standard of... 
Internal Medicine | SURVIVAL | MAINTENANCE | MEDICINE, GENERAL & INTERNAL | II MULTICENTER | B-CELL | ADVANCED FOLLICULAR LYMPHOMA | CYCLOPHOSPHAMIDE | VINCRISTINE | NON-HODGKINS-LYMPHOMA | COMBINATION | CHEMOTHERAPY | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Nitrogen Mustard Compounds - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cyclophosphamide - adverse effects | Vincristine - administration & dosage | Adult | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Prednisone - adverse effects | Lymphoma, Mantle-Cell - drug therapy | Rituximab | Treatment Outcome | Nitrogen Mustard Compounds - adverse effects | Disease-Free Survival | Bendamustine Hydrochloride | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - adverse effects | Aged | Infusions, Intravenous | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Usage | Chemotherapy | Bendamustine | Patient outcomes | Lymphomas | Research | Drug therapy | Comparative analysis | Cancer | Antimitotic agents | Care and treatment | Antineoplastic agents | Analysis | Bone marrow | Hematology
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 03/2012, Volume 158, Issue 3, pp. 470 - 478
Journal Article
Blood, ISSN 0006-4971, 05/2014, Volume 123, Issue 19, pp. 2944 - 2952
Journal Article
Journal Article
Annals of Hematology, ISSN 0939-5555, 01/2013, Volume 92, Issue 1, pp. 121 - 123
REGIMEN | HEMATOLOGY | CHEMOTHERAPY | BEACOPP | DISEASE | Procarbazine - administration & dosage | Recurrence | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prednisolone - administration & dosage | Nitrogen Mustard Compounds - administration & dosage | Humans | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Salvage Therapy | Male | Transplantation, Autologous | Vinblastine - administration & dosage | Hodgkin Disease - surgery | Transplantation, Homologous | Young Adult | Hodgkin Disease - radiotherapy | Nitrogen Mustard Compounds - therapeutic use | Vinblastine - analogs & derivatives | Bone Marrow Transplantation | Fatal Outcome | Hodgkin Disease - drug therapy | Vincristine - administration & dosage | Female | Graft vs Host Disease - etiology | Chemical and Drug Induced Liver Injury - etiology | Doxorubicin - administration & dosage | Reoperation | Dacarbazine - administration & dosage | Prednisone - administration & dosage | Deoxycytidine - administration & dosage | Rituximab | Etoposide - administration & dosage | Combined Modality Therapy | Bleomycin - administration & dosage | Nitrogen Mustard Compounds - adverse effects | Antineoplastic Agents, Alkylating - therapeutic use | Bendamustine Hydrochloride | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antineoplastic Agents, Alkylating - adverse effects | Deoxycytidine - analogs & derivatives | Antimitotic agents | Care and treatment | Relapse | Bone marrow | Lymphomas | Transplantation | Antineoplastic agents | Diseases | Cancer
Journal Article
Journal of Pharmacy and Pharmacology, ISSN 0022-3573, 10/2018, Volume 70, Issue 10, pp. 1357 - 1368
Journal Article